Dr. Agarwal's Health Care
add_icon

Dr. Agarwal's Health Care

502.10
+7.30
(1.48%)
Market Cap
15,915.72 Cr
PE Ratio
84.87
Volume
3,55,015.00
Day High - Low
506.25 - 491.00
52W High-Low
568.00 - 401.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
15,915.72 Cr
EPS
4.21
PE Ratio
84.87
PB Ratio
7.76
Book Value
63.88
EBITDA
614.00
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
7.93
Debt to Equity
0.52
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Dr Agarwal's Health Care held its 16th AGM on September 21, 2026. Shareholders approved audited financials for FY26, reappointed directors, and authorized remuneration revisions for top management.
positive
Dr. Agarwal's Health Care schedules its 16th AGM on September 21, 2026 via VC/OAVM. FY26 consolidated PAT rose 52.4% to ₹168 Cr; total income up 20.9% to ₹2,125 Cr.
positive
Dr. Agarwal's Health Care eyes Delhi NCR expansionAug 28, 2026
Dr. Agarwal's Health Care plans a major expansion in Delhi NCR over the next 2-3 years to strengthen its leadership position in the eye care segment.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
8,888.50
#1 1,27,802.99
59.98
#1 25,420.10
15.58
#1 2,003
38.41
52.21
1,046.00
1,01,801.30
70.31
8,536.10
18.82
1,442
4.87
53.81
768.65
67,001.10
182.82
4,768.80
11.25
427
-68.70
48.86
877.35
66,236.25
62.83
9,178.50
16.93
1,064
2.25
38.54
1,506.20
40,496.87
72.81
4,508.90
19.56
554
-1.07
58.93
1,877.70
38,372.83
48.09
7,996.30
#1 43.43
811
5.39
47.95
800.45
33,619.42
172.42
3,930.80
28.16
242
-56.00
58.36
502.10
#8 15,915.72
#8 84.87
#8 2,124.50
#3 20.92
#10 168
#1 44.36
49.09
1,412.60
14,346.25
49.22
1,746.90
11.49
282
16.17
39.77
285.00
12,310.03
#1 41.70
1,711.00
19.99
274
35.27
53.54

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
20.92 %
Net Income Growth
52.40 %
Cash Flow Change
45.32 %
ROE
38.39 %
ROCE
15.81 %
EBITDA Margin (Avg.)
1.08 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
345
369
410
429
443
476
501
507
540
578
620
Expenses
244
241
300
310
316
332
360
363
386
403
444
EBITDA
101
128
110
119
128
144
141
144
155
175
177
Operating Profit %
27 %
31 %
26 %
26 %
27 %
28 %
26 %
27 %
27 %
29 %
28 %
Depreciation
43
47
56
57
58
60
63
68
69
77
78
Interest
22
27
27
28
28
25
25
23
21
22
23
Profit Before Tax
36
54
27
33
41
59
54
54
65
77
75
Tax
13
13
9
12
13
16
16
17
21
27
20
Net Profit
23
41
18
21
28
43
38
37
44
50
55
EPS in ₹
1.94
1.39
0.43
0.45
0.73
1.04
0.95
0.94
1.07
1.25
1.43

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
752
787
1,026
1,825
2,753
3,672
3,942
Fixed Assets
551
575
702
1,293
1,746
2,523
2,870
Current Assets
146
155
228
310
759
789
573
Capital Work in Progress
8
11
28
99
118
153
244
Investments
1
0
0
34
471
264
152
Other Assets
193
201
296
399
418
731
676
Total Equity & Liabilities
752
787
1,026
1,825
2,753
3,672
3,942
Current Liabilities
146
150
206
301
400
478
462
Non Current Liabilities
339
438
586
865
974
1,267
1,361
Total Equity
267
199
234
659
1,380
1,927
2,120
Reserve & Surplus
242
177
206
622
1,330
1,835
1,993
Share Capital
7
7
7
8
9
32
32

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-56
17
44
27
-15
-11
-10
Investing Activities
-85
-46
-155
-509
-914
-750
-309
Operating Activities
103
99
164
233
346
357
519
Financing Activities
-74
-37
35
303
553
382
-220

Share Holding

% Holding
Sept 2024
Jan 2025
Feb 2025
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
37.83 %
37.73 %
32.45 %
32.45 %
32.42 %
32.42 %
32.39 %
32.36 %
32.34 %
FIIs
0.00 %
0.00 %
56.97 %
60.62 %
59.26 %
58.13 %
58.06 %
57.94 %
57.96 %
DIIs
0.00 %
0.00 %
5.10 %
5.21 %
6.44 %
7.92 %
7.78 %
7.83 %
7.72 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
4.79 %
1.61 %
1.74 %
1.41 %
1.62 %
1.68 %
1.81 %
Others
62.17 %
62.27 %
0.69 %
0.11 %
0.14 %
0.11 %
0.15 %
0.19 %
0.17 %
No of Share Holders
29
43
2,17,289
68,696
63,021
48,168
46,554
43,538
42,492

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 402.50 449.00
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 401.60 375.25
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 445.90 446.20
24 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2025 433.50 460.20
30 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2025 542.55 510.35
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2026 446.10 440.15
21 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 May 2026 448.00 461.20
02 Jul 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
02 Jul 2026 483.80 469.20
04 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Aug 2026 475.55 483.30
21 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2026 496.65 499.80

Announcements

Shareholder Meeting / Postal Ballot-Scrutinizers Report3 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM3 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2026
Reg. 34 (1) Annual Report.Aug 28, 2026
Sixteenth Annual General Meeting Of Dr Agarwals Health Care Limited To Be Held On September 21 2026Aug 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 25, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 25, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 14, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 14, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 14, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Aug 14, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 14, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Aug 14, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 04, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 04, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 04, 2026
Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026.Aug 04, 2026
Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2026
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026Jul 28, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 20, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Voting Results And The Consolidated Scrutinizers Report On The Honble NCLT Convened Meeting Of The Unsecured Creditors Of Dr. Agarwals Health Care Limited Held On July 02 2026.Jul 02, 2026
Summary Of The Proceedings Of The Honble NCLT Convened Meeting Of The Unsecured Creditors Of Dr. Agarwals Health Care Limited Held On July 02 2026Jul 02, 2026
Voting Results And The Consolidated Scrutinizers Report On The NCLT Convened Meeting Of The Equity Shareholders Of Dr. Agarwals Health Care Limited Held On July 02 2026.Jul 02, 2026
Summary Of The Proceedings Of The Honble NCLT Convened Meeting Of The Secured Creditors Of Dr. Agarwals Health Care Limited Held On July 02 2026Jul 02, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 02, 2026
Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingJul 02, 2026
Closure of Trading WindowJun 20, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJun 16, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Letter To Equity Shareholders And CreditorsJun 01, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 01, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 01, 2026
Notice Convening Meeting Of The Equity Shareholders Of The Company Pursuant To The Order Of Honble NCLT Chennai BenchJun 01, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 27, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 21, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 21, 2026
Consolidated And Standalone Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2026May 21, 2026
Board Meeting Outcome for Consolidated And Standalone Audited Financial Results For The Quarter And Year Ended March 31 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 21, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 20, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 15, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Invesco India Consumption Fund Direct-Growth
2.53%
295946
2.53%
2.53%
LIC MF Consumption Fund Direct-Growth
1.10%
98700
1.10%
1.10%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
1
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.77%
0
0.00%
0.16%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.24%
0
0.00%
0.01%
Bandhan Innovation Fund Direct-Growth
1.51%
0
0.00%
0.29%
Bandhan Large Cap Fund Direct-Growth
1.00%
0
0.00%
0.20%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Canara Robeco Conservative Hybrid Fund Direct-Growth
0.19%
0
0.00%
0.10%
Canara Robeco Focused Fund Direct-Growth
0.00%
0
0.00%
0.00%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
HDFC BSE 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Aggressive Hybrid Fund Direct-Growth
0.48%
0
0.00%
0.48%
ICICI Prudential ELSS - Tax Saver Fund Direct-Growth
0.72%
0
0.00%
0.72%
ICICI Prudential Flexi Cap Fund Direct-Growth
0.40%
0
0.00%
0.40%

Technical Indicators

RSI(14)
Neutral
42.84
ATR(14)
Less Volatile
14.78
STOCH(9,6)
Neutral
31.77
STOCH RSI(14)
Oversold
10.61
MACD(12,26)
Bearish
-2.53
ADX(14)
Weak Trend
17.27
UO(9)
Bearish
56.58
ROC(12)
Downtrend And Accelerating
-3.75
WillR(14)
Neutral
-76.15